Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 3, 2014, Pages 724-733

  Xiao, Lijun ^a,c   Wang, Dimin ^b   Li, Pingchao ^a   Jin, Yi ^a,b   Feng, Liqiang ^a   Sun, Caijun ^a   Chen, Ling ^a,d  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b ANHUI UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant; Immunogenicity; SIV; Soluble PD 1; Soluble Tim 3

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; PROGRAMMED DEATH 1 RECEPTOR; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; SOLUBLE T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS PROTEIN; DRUG CARRIER; HAVCR2 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPHARMACOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN INDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SPLEEN CELL; T LYMPHOCYTE; ADENOVIRIDAE; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; GENE VECTOR; GENETICS; IMMUNOLOGY; MONONUCLEAR CELL; SECRETION (PROCESS);

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DRUG CARRIERS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC VECTORS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MICE, INBRED C57BL; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, VIRUS; SAIDS VACCINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898425841     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27340     Document Type: Article

References (47)

1. Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE. HIV controllers: a multifactorial phenotype of spontaneous viral suppression. Clin Immunol 2011; 141:15-30; PMID:21865089
2. Sun C, Zhang L, Zhang M, Liu Y, Zhong M, Ma X, Chen L. Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys. J Infect 2010; 60:371-81; PMID:20227437; http://dx.doi.org/10.1016/j.jinf.2010.03.005
3. Assarsson E, Kambayashi T, Persson CM, Chambers BJ, Ljunggren H-G. 2B4/CD48-mediated regulation of lymphocyte activation and function. J Immunol 2005; 175:2045-9; PMID:16081768
4. Bhadra R, Gigley JP, Weiss LM, Khan IA. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A 2011; 108:9196-201; PMID:21576466; http://dx.doi.org/10.1073/pnas.1015298108
5. del Rio ML, Lucas CL, Buhler L, Rayat G, Rodriguez-Barbosa JI. HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. J Leukoc Biol 2010; 87:223-35; PMID:20007250; http://dx.doi.org/10.1189/jlb. 0809590
6. Finnefrock AC, Tang A, Li F, Freed DC, Feng M, Cox KS, Sykes KJ, Guare JP, Miller MD, Olsen DB, et al. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 2009; 182:980-7; PMID:19124741
7. Fougeray S, Brignone C, Triebel F. A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321. Vaccine 2006; 24:5426-33; PMID:16621192; http://dx.doi.org/10.1016/j.vaccine. 2006.03.050
8. Peng B, Lu C, Tang L, Yeh IT, He Z, Wu Y, Zhong G. Enhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally infected with Chlamydia muridarum. BMC Infect Dis 2011; 11:347; PMID:22168579; http://dx.doi.org/10.1186/1471-2334-11-347
9. Pilon-Thomas S, Mackay A, Vohra N, Mulé JJ. Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma. J Immunol 2010; 184:3442-9; PMID:20194714; http://dx.doi.org/10.4049/jimmunol.0904114
10. Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24:619-22; PMID:14644131; http://dx.doi.org/10.1016/j.it.2003.10.001
11. Jin HT, Ahmed R, Okazaki T. Role of PD-1 in regulating T-cell immunity. Curr Top Microbiol Immunol 2011; 350:17-37; PMID:21061197
12. Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 2012; 119:3064-72; PMID:22323453; http://dx.doi.org/10.1182/blood-2011-06-360321
13. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236:219-42; PMID:20636820; http://dx.doi.org/10. 1111/j.1600-065X.2010.00923.x
14. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6:1245-52; PMID:16286920; http://dx.doi.org/10.1038/ni1271
15. Sehrawat S, Reddy PB, Rajasagi N, Suryawanshi A, Hirashima M, Rouse BT. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog 2010; 6:e1000882; PMID:20463811; http://dx.doi.org/ 10.1371/journal.ppat.1000882
16. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-45; PMID:17304234; http://dx.doi.org/10.1038/ni1443
17. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003; 4:1102-10; PMID:14556006; http://dx.doi.org/10. 1038/ni988
18. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4; PMID:16921384; http://dx.doi.org/10.1038/nature05115
19. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Kuchroo V, Zarour HM. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 2010; 207:2175-86; PMID:20819923; http://dx.doi.org/10.1084/ jem.20100637
20. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR, Rosen HR. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009; 83:9122-30; PMID:19587053; http://dx.doi.org/10.1128/JVI.00639-09
21. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008; 205:2763-79; PMID:19001139; http://dx.doi.org/10.1084/jem.20081398
22. Kane LP. T cell Ig and mucin domain proteins and immunity. J Immunol 2010; 184:2743-9; PMID:20200285; http://dx.doi.org/10.4049/jimmunol.0902937
23. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-202; PMID:16917489; http://dx.doi.org/10.1038/nm1482
24. Ha SJ, Mueller SN, Wherry EJ, Barber DL, Aubert RD, Sharpe AH, Freeman GJ, Ahmed R. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008; 205:543-55; PMID:18332181; http://dx.doi.org/10.1084/jem.20071949
25. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L, Vanderford TH, Chennareddi L, Silvestri G, Freeman GJ, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009; 458:206-10; PMID:19078956; http://dx.doi.org/10.1038/nature07662
26. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2010; 107:14733-8; PMID:20679213; http://dx.doi.org/10.1073/pnas.1009731107
27. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010; 207:2187-94; PMID:20819927; http://dx.doi.org/10.1084/jem.20100643
28. Onlamoon N, Rogers K, Mayne AE, Pattanapanyasat K, Mori K, Villinger F, Ansari AA. Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection. Immunology 2008; 124:277-93; PMID:18266718; http://dx.doi.org/10.1111/j.1365- 2567.2007.02766.x
29. Song MY, Park SH, Nam HJ, Choi DH, Sung YC. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1. J Immunother 2011; 34:297-306; PMID:21389868; http://dx.doi.org/10.1097/CJI. 0b013e318210ed0e
30. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8:247-58; PMID:18323851; http://dx.doi.org/10.1038/nri2274
31. Amexis G, Young NS. Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus. Viral Immunol 2007; 20:657-63; PMID:18158738; http://dx.doi.org/10.1089/vim.2007.0029
32. Bilello JP, Manrique JM, Shin YC, Lauer W, Li W, Lifson JD, Mansfield KG, Johnson RP, Desrosiers RC. Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. J Virol 2011; 85:12708-20; PMID:21900170; http://dx.doi.org/10.1128/JVI.00865-11
33. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T, et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011; 473:523-7; PMID:21562493; http://dx.doi.org/10.1038/nature10003
34. Holman DH, Wang D, Raja NU, Luo M, Moore KM, Woraratanadharm J, Mytle N, Dong JY. Multiantigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 2008; 26:2627-39; PMID:18395306; http://dx.doi.org/10.1016/j.vaccine.2008.02.053
35. Grifantini R, Finco O, Bartolini E, Draghi M, Del Giudice G, Kocken C, Thomas A, Abrignani S, Grandi G. Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid. Eur J Immunol 1998; 28:1225-32; PMID:9565362; http://dx.doi.org/10.1002/(SICI) 1521-4141(199804)28: 04〈1225: :AIDIMMU1225〉3.0.CO;2-6
36. Johansson BE, Moran TM, Kilbourne ED. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc Natl Acad Sci U S A 1987; 84:6869-73; PMID:2958849; http://dx.doi.org/10.1073/pnas.84.19.6869
37. Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue F-Y, Gyenes G, Wong D, Klein MB, Saeed S, et al. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol 2010; 40:2493-505; PMID:20623550; http://dx.doi.org/10.1002/eji.201040340
38. Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH, Murphy WJ, Azuma M, Anderson AC, Kuchroo VK, et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 2011; 117:4501-10; PMID:21385853; http://dx.doi.org/10.1182/blood-2010-10-310425
39. Zhou J, Cheung AKL, Tan Z, Wang H, Yu W, Du Y, Kang Y, Lu X, Liu L, Yuen KY, et al. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest 2013; 123:2629-42; PMID:23635778; http://dx.doi.org/10.1172/ JCI64704
40. Zhou J, Cheung AKL, Liu H, Tan Z, Tang X, Kang Y, Du Y, Wang H, Liu L, Chen Z. Potentiating functional antigen-specific CD8 + T cell immunity by a novel PD1 isoform-based fusion DNA vaccine. Mol Ther 2013; 21:1445-55; PMID:23587922; http://dx.doi.org/10.1038/mt.2013.63
41. Geng H, Zhang G-M, Li D, Zhang H, Yuan Y, Zhu H-G, Xiao H, Han LF, Feng ZH. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol 2006; 176:1411-20; PMID:16424168
42. Rahman AN, Clayton K, Mujib S, Fong IW, Ostrowski MA.TIM-3 and Its Immunoregulatory Role in HIV Infection. J Clin Cell Immunol 2012; S7:007
43. Casimiro DR, Tang A, Chen L, Fu TM, Evans RK, Davies ME, Freed DC, Hurni W, Aste-Amezaga JM, Guan L, et al. Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 2003; 77:7663-8; PMID:12805466; http://dx.doi.org/10.1128/JVI.77.13.7663-7668.2003
44. Hu X, Meng W, Dong Z, Pan W, Sun C, Chen L. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice. Virus Res 2011; 155:156-62; PMID:20883733; http://dx.doi.org/10.1016/j. virusres.2010.09.014
45. Zhang Y, Sun C, Feng L, Xiao L, Chen L. Enhancement of Gag-specific but reduction of Env- and Pol-specific CD8+ T cell responses by simian immunodeficiency virus nonstructural proteins in mice. AIDS Res Hum Retroviruses 2012; 28:374-83; PMID:21736424; http://dx.doi.org/10.1089/aid.2011.0061
46. Meng W, Pan W, Zhang AJX, Li Z, Wei G, Feng L, Dong Z, Li C, Hu X, Sun C, et al. Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases. PLoS One 2013; 8:e66276; PMID:23824680; http://dx.doi.org/10.1371/journal.pone. 0066276
47. Sun C, Feng L, Zhang Y, Xiao L, Pan W, Li C, Zhang L, Chen L. Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques. J Virol 2012; 86:11031-42; PMID:22855499; http://dx.doi.org/10.1128/ JVI.00783-12